Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2006; 12(44): 7126-7135
Published online Nov 28, 2006. doi: 10.3748/wjg.v12.i44.7126
Published online Nov 28, 2006. doi: 10.3748/wjg.v12.i44.7126
Figure 1 Construction and characterization of HCV E2 DNA vaccine.
A secreted form of HCV E2 protein generated by removing the carboxyl-terminal hydrophobic region and replacing the hypervariable region 1 with the signal peptide sequence of the tissue plasminogen activator (tPAs) was cloned into a DNA vaccine vector pBISIA24. The construction of E2 DNA vaccine, pBISIA24-tPAs-tE2, is schematically presented. TE 671 cells were transfected with pBISIA24 (lane 1) or pBISIA24-tPAs-tE2 (lanes 2 and 3). Cell lysates (lanes 1 and 2) and culture medium (lane 3) were analyzed in immunoblotting using an E2-specific antibody.
- Citation: Li YP, Kang HN, Babiuk LA, Liu Q. Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models. World J Gastroenterol 2006; 12(44): 7126-7135
- URL: https://www.wjgnet.com/1007-9327/full/v12/i44/7126.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i44.7126